Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Ann Emerg Med. 2015 Apr 29;66(5):466–474. doi: 10.1016/j.annemergmed.2015.04.003

Table 2.

Adverse events by group

Intervention
(n=96)
Control
(n=53)
Sham
(n=56)
In lab % (95% CI) 1.0%, (0, 5.7) 0%, (0, 6.7) 1.8%, (0,9.6)
  Hematoma 0% (0, 3.8) 0% (0, 6.7) 1.8%, (0, 9.6)
  Excess Bleeding 1.0% (0, 5.7) 0% (0, 6.7) 0% (0, 6.4)
At Home% (95% CI) 15.7%, (8.6, 25.3) 13.0% (4.9, 26.2) 10.9% (3.6, 23.6)
  Bruise 14.4% (7.7, 23.9) 8.6% (2.4, 20.8) 6.5% (1.4, 17.9)
  Redness 0% (0, 4.3) 0% (0, 7.8) 4.3% (0.5, 14.8)
  Other 1.2% (0, 6.5) 4.3% (0.5, 14.8) 0% (0, 7.7)